S Kalyanasundaram, former managing director of GlaxoSmithKline Pharmaceuticals, will join Sun Pharmaceutical Industries, the country’s largest drug manufacturer in terms of market capitalisation, as one of its top three executives.
He is head, commercial excellence, for the Asia-Pacific region of GSK, the world’s second largest drug company. Sources said Sun Pharma has not yet finalised the role and designation of his responsibilities, but he will join by April.
Sun Pharma’s day to day operations are mainly headed by Dilip Shanghvi, chairman and managing director, and Sudhir Valia, whole time director.
Kalyanasundaram, known in industry circles as Kal, was appointed GSK’s managing director in 2003, succeeding V Thyagarajan.
A science graduate from Madurai University and a qualified chartered accountant, Kalyanasundaram had joined Wellcome as a commercial advisor in New Zealand in 1988.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app